Atri Elias, Wong Vivian, Barengo Noel C, Nieder Alan M, Polackwich Alan S
Urology, Florida International University Herbert Wertheim College of Medicine, Miami, USA.
Translational Medicine, Florida International University Herbert Wertheim College of Medicine, Miami, USA.
Cureus. 2020 Nov 5;12(11):e11350. doi: 10.7759/cureus.11350.
There are only two three-piece inflatable penile prostheses (IPP) available to patients in the American market: the AMS (American Medical Systems) 700 series (Boston Scientific, Massachusetts) and the Coloplast Titan® series (Coloplast, Minnesota), and data comparing the two are scant. The aim of our study was to summarize the current scientific evidence comparing the two. A systematic literature review was conducted on PubMed. A 10-year filter was placed to include only studies published after Coloplast launched the Titan Touch® release pump. Eligibility criteria included articles discussing specifically the AMS 700 and Coloplast Titan® models. Further searches for studies on patient/partner satisfaction were conducted. Abstracts were reviewed to include studies focusing specifically on the models we are studying and studies on patient satisfaction using the Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) questionnaire. The Coloplast device demonstrated slightly greater resistance to the stimulated forces of penetration and gravity. Coloplast implants coated with vancomycin/gentamicin had the highest infection rate followed by the AMS penile prosthesis and the rifampin/gentamicin coating had the lowest infection rate. Prosthesis durability and survival were similar between both brands. Overall satisfaction was high but comparisons are inconsistent. The literature is inconclusive about which device is superior. We suggest randomized, multicenter, prospective studies to help further elucidate the highlights of each product.
在美国市场上,患者可获得的三件式可充气阴茎假体(IPP)只有两种:美国医疗系统公司(AMS)的700系列(波士顿科学公司,马萨诸塞州)和康乐保公司的Titan®系列(康乐保公司,明尼苏达州),而比较这两种产品的数据很少。我们研究的目的是总结目前比较这两种产品的科学证据。我们在PubMed上进行了系统的文献综述。设置了10年的筛选条件,只纳入康乐保公司推出Titan Touch®释放泵后发表的研究。纳入标准包括专门讨论AMS 700和康乐保Titan®型号的文章。进一步搜索了关于患者/伴侣满意度的研究。对摘要进行了审查,纳入了专门关注我们正在研究的型号的研究,以及使用治疗满意度勃起功能障碍问卷(EDITS)对患者满意度进行研究的文章。康乐保的产品在抵抗穿透和重力的刺激力方面表现出略高的耐受性。涂有万古霉素/庆大霉素的康乐保植入物感染率最高,其次是AMS阴茎假体,而涂有利福平/庆大霉素的感染率最低。两个品牌的假体耐用性和存活率相似。总体满意度较高,但比较结果并不一致。关于哪种设备更优越,文献尚无定论。我们建议进行随机、多中心、前瞻性研究,以帮助进一步阐明每种产品的特点。